This Program Project Grant (PPG) application seeks to discover and characterize synthetic, small molecule compounds that may be effective in the treatment of human cancer. Four interrelated projects are proposed. The first project will employ the tools of biochemistry and molecular biology to discover the molecular targets of three natural products known to have potent cytotoxic activity. The second project will employ a peptidomimetic approach to discover synthetic organic compounds capable of rendering tumor cells susceptible to programmed cell death. The third project will employ both a high throughput screening (HTS) approach and a structure-activity-relationship (SAR) by nuclear magnetic resonance (NMR) approach to discover synthetic organic compounds capable of inhibiting an entirely novel growth regulatory pathway. The final project will employ both an HTS approach and an SAR-by-NMR approach to discover synthetic organic compounds capable of inhibiting the hypoxia response pathway of mammalian cells. All four of these projects will entail the combined use of chemical, biophysical and biochemical/molecular biological research. The goals of this PPG application could not be met without the unified contribution of the chemists, biophysicists and biologists that form the leadership structure of the PPG team. A unique and critical aspect of the research program will entail the development and use of a core facility for high throughput drug screening (HTS). This facility will have access to a library of 350,000 diverse, heterocyclic drug-like chemicals. Two of the four projects will make specific use of the HTS core facility for the critical objective of discovering small, synthetic compounds capable of modulating specific intracellular pathways that are highly relevant to human cancer. Beyond serving as the direct financial support for the proposed research objectives unique to this application, funding of this PPG will substantially enhance research at the interface of chemical and biomedical science at the host institution.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA095471-05
Application #
7116474
Study Section
Special Emphasis Panel (ZCA1-GRB-W (J2))
Program Officer
Lees, Robert G
Project Start
2002-09-01
Project End
2007-08-31
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
5
Fiscal Year
2006
Total Cost
$3,683,468
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Biochemistry
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Qi, Chen; Wang, Xin; Shen, Zhirong et al. (2018) Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells. Cell Res 28:544-555
Zhang, Lu; Theodoropoulos, Panayotis C; Eskiocak, Ugur et al. (2016) Selective targeting of mutant adenomatous polyposis coli (APC) in colorectal cancer. Sci Transl Med 8:361ra140
Guo, Yirui; Scheuermann, Thomas H; Partch, Carrie L et al. (2015) Coiled-coil coactivators play a structural role mediating interactions in hypoxia-inducible factor heterodimerization. J Biol Chem 290:7707-21
Scheuermann, Thomas H; Stroud, Daniel; Sleet, Christopher E et al. (2015) Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2. J Med Chem 58:5930-41
Rose, Tristan E; Lawson, Kenneth V; Harran, Patrick G (2015) Large ring-forming alkylations provide facile access to composite macrocycles. Chem Sci 6:2219-2223
Zhang, Yongyou; Desai, Amar; Yang, Sung Yeun et al. (2015) TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science 348:aaa2340
Iscla, Irene; Wray, Robin; Wei, Shuguang et al. (2014) Streptomycin potency is dependent on MscL channel expression. Nat Commun 5:4891
Kilgore, Jessica A; Du, Xinlin; Melito, Lisa et al. (2013) Identification of DNMT1 selective antagonists using a novel scintillation proximity assay. J Biol Chem 288:19673-84
Lawson, Kenneth V; Rose, Tristan E; Harran, Patrick G (2013) Template-constrained macrocyclic peptides prepared from native, unprotected precursors. Proc Natl Acad Sci U S A 110:E3753-60
Wang, Gelin; Wang, Xiaoming; Yu, Hong et al. (2013) Small-molecule activation of the TRAIL receptor DR5 in human cancer cells. Nat Chem Biol 9:84-9

Showing the most recent 10 out of 67 publications